Gottlieb, A., Gisondi, P., Eells, J., Peterson, L. and Kavanaugh, A. (2020) “Durability of Response in Patients with Psoriatic Arthritis Treated with Certolizumab Pegol over 216 Weeks: Post-Hoc Analyses from the RAPID-PsA Study”, SKIN The Journal of Cutaneous Medicine, 4(1), p. S2. Available at: https://jofskin.org/33014/index.php/skin/article/view/801 (Accessed: 3 July 2024).